High Quality Clinical Grade sgRNA For CRISPR Based Therapies
Source: Synthego Corporation

Synthego offers an expert quality team, a wealth of CRISPR expertise, a proven track record of successful GMP campaigns, and extensive testing and stability studies to their partners from discovery to the clinic phase of CRISPR-based therapy development. Their new next-generation GMP facility is designed to accelerate growth of CRISPR-mediated cell and gene therapies.
Learn about three different grades of high-quality synthetic sgRNAs that will help support every step of your process.
access the Brochure!
Log In
Get unlimited access to:
Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue.
X
Enter your credentials below to log in. Not yet a member of Cell & Gene? Subscribe today.
Subscribe to Cell & Gene
X
Subscribe to Cell & Gene
Synthego Corporation
This website uses cookies to ensure you get the best experience on our website. Learn more